Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting. The COSMiC Prospective Prostate Cancer Registry

NCT02364531 is registered in ClinicalTrials.gov with Janssen Inc. as lead sponsor.

NCT NCT02364531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02364531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting. The COSMiC Prospective Prostate Cancer Registry
Lead sponsor
Janssen Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
November 1, 2018
Enrollment
194 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms